Brief: Neubase Therapeutics Says Nasdaq Notified Co It Was Eligible For Additional 180 Calendar Day Period To Regain Compliance With Minimum Bid Price Requirement
29/03/2023 22:22
March 29 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS-NASDAQ NOTIFIED CO IT WAS ELIGIBLE
FOR
ADDITIONAL 180 CALENDAR DAY PERIOD TO REGAIN COMPLIANCE WITH
MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: [https://bit.ly/3zhiEul]
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet